Literature DB >> 30031255

Heterozygous HTRA1 mutations with mimicking symptoms of CARASIL in two families.

Yu Kono1, Kenya Nishioka2, Yuanzhe Li2, Yo Komatuzaki3, Yuta Ito3, Hiroyo Yoshino4, Ryota Tanaka2, Yasuyuki Iguchi5, Nobutaka Hattori2.   

Abstract

The term cerebral small vessel disease (SVD) refers to a group of pathological processes with various etiologies that affect the small arteries, arterioles, venules, and capillaries of the brain. SVD occurs in approximately 5% of patients. Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL),a recessive form of heritable SVD, is caused by a mutation in the high temperature requirement A serine peptidase (HTRA1) gene. Recently, heterozygous mutations in HTRA1 were identified in patients with symptomatic SVD. We identified two families harboring HTRA1 (p.S284 N and p.V216 M) heterozygous mutations with symptoms that mimicked common symptoms of CARASIL.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alopecia; CARASIL; Cerebral infarction; HTRA1; Small vessel disease

Mesh:

Substances:

Year:  2018        PMID: 30031255     DOI: 10.1016/j.clineuro.2018.07.009

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  4 in total

1.  Candesartan prevents arteriopathy progression in cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy model.

Authors:  Taisuke Kato; Ri-Ichiroh Manabe; Hironaka Igarashi; Fuyuki Kametani; Sachiko Hirokawa; Yumi Sekine; Natsumi Fujita; Satoshi Saito; Yusuke Kawashima; Yuya Hatano; Shoichiro Ando; Hiroaki Nozaki; Akihiro Sugai; Masahiro Uemura; Masaki Fukunaga; Toshiya Sato; Akihide Koyama; Rie Saito; Atsushi Sugie; Yasuko Toyoshima; Hirotoshi Kawata; Shigeo Murayama; Masaki Matsumoto; Akiyoshi Kakita; Masato Hasegawa; Masafumi Ihara; Masato Kanazawa; Masatoyo Nishizawa; Shoji Tsuji; Osamu Onodera
Journal:  J Clin Invest       Date:  2021-11-15       Impact factor: 14.808

Review 2.  HTRA1-Related Cerebral Small Vessel Disease: A Review of the Literature.

Authors:  Masahiro Uemura; Hiroaki Nozaki; Taisuke Kato; Akihide Koyama; Naoko Sakai; Shoichiro Ando; Masato Kanazawa; Nozomi Hishikawa; Yoshinori Nishimoto; Kiran Polavarapu; Atchayaram Nalini; Akira Hanazono; Daisuke Kuzume; Akihiro Shindo; Mohammad El-Ghanem; Arata Abe; Aki Sato; Mari Yoshida; Takeshi Ikeuchi; Ikuko Mizuta; Toshiki Mizuno; Osamu Onodera
Journal:  Front Neurol       Date:  2020-07-03       Impact factor: 4.003

3.  Identified novel heterozygous HTRA1 pathogenic variants in Chinese patients with HTRA1-associated dominant cerebral small vessel disease.

Authors:  Mei-Jiao Chen; Yi Zhang; Wen-Jiao Luo; Hai-Lin Dong; Qiao Wei; Juan Zhang; Qi-Qi Ruan; Wang Ni; Hong-Fu Li
Journal:  Front Genet       Date:  2022-08-10       Impact factor: 4.772

Review 4.  Report of two pedigrees with heterozygous HTRA1 variants-related cerebral small vessel disease and literature review.

Authors:  Hui Zhou; Bin Jiao; Ziyu Ouyang; Qihui Wu; Lu Shen; Liangjuan Fang
Journal:  Mol Genet Genomic Med       Date:  2022-08-10       Impact factor: 2.473

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.